BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 18510482)

  • 1. Gene therapy to prevent occlusion of venous bypass grafts.
    Bhardwaj S; Roy H; Ylä-Herttuala S
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):641-52. PubMed ID: 18510482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene delivery to aortocoronary saphenous vein grafts in a large animal model of intimal hyperplasia.
    Petrofski JA; Hata JA; Gehrig TR; Hanish SI; Williams ML; Thompson RB; Parsa CJ; Koch WJ; Milano CA
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):27-33. PubMed ID: 14752409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary artery bypass graft failure after on-pump and off-pump coronary artery bypass: findings from PREVENT IV.
    Magee MJ; Alexander JH; Hafley G; Ferguson TB; Gibson CM; Harrington RA; Peterson ED; Califf RM; Kouchoukos NT; Herbert MA; Mack MJ;
    Ann Thorac Surg; 2008 Feb; 85(2):494-9; discussion 499-500. PubMed ID: 18222251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiographic predictors of 6-month patency of bypass grafts implanted to the right coronary artery a prospective randomized comparison of gastroepiploic artery and saphenous vein grafts.
    Glineur D; D'hoore W; El Khoury G; Sondji S; Kalscheuer G; Funken JC; Rubay J; Poncelet A; Astarci P; Verhelst R; Noirhomme P; Hanet C
    J Am Coll Cardiol; 2008 Jan; 51(2):120-5. PubMed ID: 18191734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The radial artery: a forgotten conduit.
    Gaudino M; Crea F; Cammertoni F; Massetti M
    Ann Thorac Surg; 2015 Apr; 99(4):1479-85. PubMed ID: 25725926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catheter-based infrared light scanner as a tool to assess conduit quality in coronary artery bypass surgery.
    Burris N; Schwartz K; Tang CM; Jafri MS; Schmitt J; Kwon MH; Toshinaga O; Gu J; Brown J; Brown E; Pierson R; Poston R
    J Thorac Cardiovasc Surg; 2007 Feb; 133(2):419-27. PubMed ID: 17258576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial.
    Alexander JH; Hafley G; Harrington RA; Peterson ED; Ferguson TB; Lorenz TJ; Goyal A; Gibson M; Mack MJ; Gennevois D; Califf RM; Kouchoukos NT;
    JAMA; 2005 Nov; 294(19):2446-54. PubMed ID: 16287955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrograde recanalization of a chronic total occlusion of a saphenous vein graft.
    Sachdeva R; Uretsky BF
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):575-8. PubMed ID: 19496115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inadvertent dilation of a saphenous vein graft stenosis by the PercuSurge GuardWire distal protection balloon.
    Sharma N; Kalaria VG
    Catheter Cardiovasc Interv; 2003 Jul; 59(3):346-9. PubMed ID: 12822155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial quantitative coronary analyses for the evaluation of one-year change in saphenous vein grafts.
    Suzuki N; Kozuma K; Ueno Y; Nagaoka K; Kyono H; Ishikawa S; Watanabe H; Yokoyama N; Takeshita S; Isshiki T
    Ann Thorac Surg; 2008 Feb; 85(2):525-9. PubMed ID: 18222257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term performance of an external stent for saphenous vein grafts: the VEST IV trial.
    Taggart DP; Webb CM; Desouza A; Yadav R; Channon KM; De Robertis F; Di Mario C
    J Cardiothorac Surg; 2018 Nov; 13(1):117. PubMed ID: 30453984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of saphenous vein graft radiographic markers on clinical events and angiographic parameters.
    Olenchock SA; Karmpaliotis D; Gibson WJ; Murphy SA; Southard MC; Ciaglo L; Buros J; Mack MJ; Alexander JH; Harrington RA; Califf RM; Kouchoukos NT; Ferguson TB; Gibson CM
    Ann Thorac Surg; 2008 Feb; 85(2):520-4. PubMed ID: 18222256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy and coronary artery bypass grafting: current perspectives.
    George SJ; Channon KM; Baker AH
    Curr Opin Mol Ther; 2006 Aug; 8(4):288-94. PubMed ID: 16955691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of saphenous vein and internal thoracic artery graft patency by coronary system.
    Sabik JF; Lytle BW; Blackstone EH; Houghtaling PL; Cosgrove DM
    Ann Thorac Surg; 2005 Feb; 79(2):544-51; discussion 544-51. PubMed ID: 15680832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath.
    Vijayan V; Shukla N; Johnson JL; Gadsdon P; Angelini GD; Smith FC; Baird R; Jeremy JY
    J Vasc Surg; 2004 Nov; 40(5):1011-9. PubMed ID: 15557918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
    Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do radial-artery grafts have a superior 1-year patency to saphenous-vein grafts?
    Tatoulis J
    Nat Clin Pract Cardiovasc Med; 2005 Mar; 2(3):126-7. PubMed ID: 16265451
    [No Abstract]   [Full Text] [Related]  

  • 18. External Support for Saphenous Vein Grafts in Coronary Artery Bypass Surgery: A Randomized Clinical Trial.
    Goldstein DJ; Puskas JD; Alexander JH; Chang HL; Gammie JS; Marks ME; Iribarne A; Vengrenyuk Y; Raymond S; Taylor BS; Yarden O; Orion E; Dagenais F; Ailawadi G; Chu MWA; DiMaio JM; Narula J; Moquete EG; O'Sullivan K; Williams JB; Crestanello JA; Jessup M; Rose EA; Scavo V; Acker MA; Gillinov M; Mack MJ; Gelijns AC; O'Gara PT; Moskowitz AJ; Bagiella E; Voisine P
    JAMA Cardiol; 2022 Aug; 7(8):808-816. PubMed ID: 35675092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arterial grafts do not counteract target vessel occlusion.
    Bartnes K; Hermansen SE; Dahl-Eriksen Ø; Bahar R; Busund R; Sørlie DG; Myrmel T
    Eur J Cardiothorac Surg; 2013 Nov; 44(5):e320-4. PubMed ID: 23956270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery bypass graft disease.
    Nwasokwa ON
    Ann Intern Med; 1995 Oct; 123(7):528-45. PubMed ID: 7661498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.